Page 26 - Sanket Koul

Small, medium-sized pharma firms gear up to comply with revised Schedule M

Pharma groups had wanted two year extension, will raise concerns with govt

Medtech industry expects regulatory body to reclassify more medical devices

CDSCO to initiate workshops; industry says step will bring regulatory uniformity

'A milestone': PM Narendra Modi unveils genome data of 10K Indians

Genome sequencing, a laboratory technique used to decode the entire genetic composition of an organism or cell type, lies at the heart of the project

US pharma major Eli Lilly to establish second Indian GCC in Hyderabad

Company plans to employ 1,000-1,500 skilled professionals; GCC to focus on automation, AI

HMPV scare: Centre asks states to enhance surveillance, create awareness

Seven HMPV cases detected in India; health secretary says country prepared for any potential surge in respiratory illness cases

HMPV outbreak: India reports 5 cases, govt says there's no need to panic

Health Min says current data shows no unusual surge in influenza-like respiratory illnesses

No unusual rise in flu-like cases in India, says govt amid China HMPV surge

Health Ministry convenes monitoring group meeting over hMPV surge in China

MSME Pharma units get breather as govt extends Schedule M deadline

Pharma cos with turnover of Rs 250 cr or less can submit an application to the central drugs regulator for one one-year extension

Budget wishlist: Pharma firms seek simplified taxes, stronger PLI scheme

Among other demands is the removal of Section 194R related to marketing samples that would ease business operations

No cause for alarm: Indian health officials on hMPV spread in China

The National Centre for Disease Control (NCDC) is also monitoring respiratory and seasonal influenza cases, official sources told news agency ANI

CDSCO, WB drugs body seize spurious drugs worth Rs 6.6 Cr in Kolkata

Anti-cancer, anti-diabetic drugs, labelled as manufactured in various countries, among those recovered without any supporting documents

Budget: Experts push for higher health, edu fund, duty cuts on cancer care

A key demand discussed in the meeting was the reduction of customs duty and other levies on the import of radiation machines used to treat cancer

Mankind Pharma inks pact with Innovent for immunotherapy drug in India

Drug used to treat non-small cell lung cancer, liver cancer, gastric cancer, esophageal cancer, endometrial cancer and Hodgkin's lymphoma will be priced competitively

CDSCO flags 2 drugs as spurious, another 111 fail quality test in Nov '24

While the CDSCO alert has named the brands for which they found spurious samples, the alert, however, does not name the drugmakers

Budget wishlist: Hospitals want rise in allocation, better PMJAY rates

According to the Nathealth-Healthcare Federation of India, the sector is pushing for an increase in healthcare spending to 2.5 per cent of the GDP

Action likely against AbbVie executive who signed self-declaration

Pharma cos and docs say medical conferences have declined since March after UCPMP was notified

Pharma dept reprimands AbbVie Healthcare for unethical marketing practices

Company sponsored 'extravagant pleasure trips' abroad of 30 doctors, violating code on pharmaceutical marketing practices

Centre mulls adding more Centres of Excellence for rare disease patients

2-3 new CoEs likely to be added to the current count of 12

IITs report rise in job offers, international placements in Phase-1

Commenting on the ongoing placement season, Prof Naresh Varma Datla, professor-in-charge, Office of Career Services (OCS) at IIT-D, said that the institute has had a very good start

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The ceiling prices of seven other drugs were revised to include the impact of the 0.00551 per cent increase in drug prices in the National List of Essential Medicines